On August 13, 2025, the White House issued an executive order aimed at strengthening the resilience of the American pharmaceutical supply chain. This order establishes a framework for filling the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR) with a focus on domestic production of essential medicines. It underscores the current reliance on foreign sources for active pharmaceutical ingredients (APIs) and outlines a timeline for identifying critical drugs and securing a six-month supply of APIs to ensure national health security.

The order requires the Assistant Secretary for Preparedness and Response (ASPR) to work with various federal agencies to create a list of approximately 26 critical drugs within 30 days. This list will inform the filling of the SAPIR, intended to decrease dependence on foreign suppliers and address potential supply chain vulnerabilities. Furthermore, the ASPR is responsible for providing regular updates on essential medicines and developing plans for future expansions of the repository.

Overall, this executive order illustrates the administration’s commitment to protecting public health through strategic stockpiling and initiatives for domestic production. By tackling the limitations of prior efforts and concentrating on critical drug supplies, the order seeks to enhance the nation’s ability to respond effectively to health emergencies. The implementation of this order will be contingent on available funding and adherence to existing legal frameworks.

Original: article